Skip to main content
Palo Alto Networks logo

Palo Alto Networks

Security and trust center evidence

paloaltonetworks.comSecurityLast verified 17 Sep 2026

Summary

Palo Alto Networks has 2 registry-verified rows in the CertReports index, last verified 17 Sep 2026. The strongest row is FedRAMP: FedRAMP Authorized. This page is independent of the vendor’s own trust centre: dates, sources and caveats come from CertReports captures.

Reviewer brief

As of 17 Sep 2026, Palo Alto Networks is listed in the FedRAMP registry as FedRAMP Authorized, with the authorization issued on 09 Dec 2024 and audited by Fortreum, LLC. As of 17 Sep 2026, Palo Alto Networks is listed in the EU-US Data Privacy Framework registry as Active, covering the SW-US Certification, EU-US Certification, and UK Extension Certification, originally issued 30 May 2019 and set to expire 06 Mar 2027. As of 17 Sep 2026, no public evidence found for SOC 2 for Palo Alto Networks. As of 17 Sep 2026, no public evidence found for HIPAA for Palo Alto Networks. As of 17 Sep 2026, no subprocessor evidence rows were supplied for Palo Alto Networks.

  • FedRAMP: listed in FedRAMP registry as FedRAMP Authorized, issued 09 Dec 2024, audited by Fortreum, LLC (as of 17 Sep 2026).
  • EU-US Data Privacy Framework: listed in DPF registry as Active (SW-US, EU-US, UK Extension Certifications), issued 30 May 2019, expires 06 Mar 2027 (as of 17 Sep 2026).
  • SOC 2 and HIPAA: no public evidence found for Palo Alto Networks (as of 17 Sep 2026).

Facts only, each dated; nothing here is inferred, scored or advised. Brief generated 17 Sep 2026; it is regenerated whenever a row changes.

Among security vendors

2verified rows

Category median 1, across 174 indexed security vendors. Palo Alto Networks has more verified rows than 91 percent of them.

cloud-securitynetwork-securitythreat-intelligencezero-trust

Compliance grid

Subprocessors

No subprocessor list captured yet.

Similar vendors with evidence

Related by product tags and the Security category, ranked by shared tags, description similarity and overlapping evidence. Never by popularity.